» Authors » Michal Yalon

Michal Yalon

Explore the profile of Michal Yalon including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 37
Citations 1465
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Qawasmi F, Segev M, Sobah T, Gorenstein L, Abebe-Campino G, Hoffmann C, et al.
J Magn Reson Imaging . 2024 Dec; PMID: 39653425
Background: Pediatric brain cancer survivors often experience hypothalamic-pituitary dysfunction due to cranial irradiation and chemotherapy. While hormone deficiencies have been studied, the changes in pituitary size and shape on long-term...
2.
Gorenstein L, Shrot S, Ben-Ami M, Stern E, Yalon M, Hoffmann C, et al.
Radiother Oncol . 2024 Apr; 196:110268. PMID: 38641261
Background And Purpose: Multiple studies demonstrated hypothalamic-pituitary dysfunction in survivors of pediatric brain tumors. However, few studies investigated the trajectories of pituitary height in these patients and their associations with...
3.
Dror Levinsky M, Brenner B, Yalon M, Levi Z, Livneh Z, Cohen Z, et al.
Cancers (Basel) . 2023 Feb; 15(3). PMID: 36765532
Personalized vaccines against patient-unique tumor-associated antigens represent a promising new approach for cancer immunotherapy. Vaccine efficacy is assessed by quantification of changes in the frequency and/or the activity of antigen-specific...
4.
Stern E, Ben-Ami M, Gruber N, Toren A, Caspi S, Abebe-Campino G, et al.
Neuro Oncol . 2023 Jan; 25(7):1345-1354. PMID: 36633935
Background: Endocrine deficiencies, including hypothalamic-pituitary-gonadal axis (HPGA) impairment, are common in survivors of childhood and adolescent medulloblastoma. Still, data regarding pubertal development and fecundity are limited, and few studies assessed...
5.
Eytan K, Versano Z, Oren R, Jacob-Hirsch J, Leitner M, Harmelin A, et al.
Front Oncol . 2022 Sep; 12:959133. PMID: 36091130
We found that pediatric glioblastoma (PED-GBM) cell lines from diffuse intrinsic pontine glioma (DIPG) carrying the H3K27M mutation or from diffuse hemispheric glioma expressing the H3G34R mutation are sensitive to...
6.
Ollech A, Yalon M, Abebe-Campino G, Molho-Pessach V, Finklestein E, Cohen H, et al.
Acta Derm Venereol . 2021 Jul; 101(7):adv00501. PMID: 34230982
Targeted medications and immunotherapies are being developed to specifically target the pathways involved in tumours. There is limited experience with these new medications and their cutaneous side-effects in the paediatric...
7.
Durno C, Ercan A, Bianchi V, Edwards M, Aronson M, Galati M, et al.
J Clin Oncol . 2021 May; 39(25):2779-2790. PMID: 33945292
Purpose: Constitutional mismatch repair deficiency syndrome (CMMRD) is a lethal cancer predisposition syndrome characterized by early-onset synchronous and metachronous multiorgan tumors. We designed a surveillance protocol for early tumor detection...
8.
Soleman J, Dvir R, Ben-Sira L, Yalon M, Boop F, Constantini S, et al.
Childs Nerv Syst . 2021 Apr; 37(5):1449-1459. PMID: 33821340
Traditional management of newly diagnosed pediatric brain tumors (PBTs) consists of cranial imaging, typically magnetic resonance imaging (MRI), and is frequently followed by tissue diagnosis, through either surgical biopsy or...
9.
Dodgshun A, Fukuoka K, Edwards M, Bianchi V, Das A, Sexton-Oates A, et al.
Acta Neuropathol . 2020 Sep; 140(5):765-776. PMID: 32895736
Replication repair deficiency (RRD) leading to hypermutation is an important driving mechanism of high-grade glioma (HGG) occurring predominantly in the context of germline mutations in RRD-associated genes. Although HGG presents...
10.
Yalon M, Toren A, Jabarin D, Fadida E, Constantini S, Mehrian-Shai R
Front Oncol . 2019 May; 9:327. PMID: 31114757
Pediatric brain tumors are the most common solid tumor type and the leading cause of cancer-related death in children. The immune system plays an important role in cancer pathogenesis and...